Arthur E. Hoffmann Jr.

Partner
About

Arthur E. Hoffmann, Jr. is a product liability lawyer with more than two decades of experience working with companies to mitigate product liability risk and defend litigation wherever it arises.  Arthur has a deep knowledge of the complex science and medicine involved in claims that product use is linked to adverse health outcomes.  He is adept at using that knowledge to analyze the complicated issues these claims involve and to integrate that analysis with the law, leading to cost-effective, pragmatic, solutions.  Arthur’s practice is global in scope, and he has represented clients’ interests in countries throughout the European Union, the United Kingdom, and in Asia, as well as in the United States.  As part of his work in representing manufacturers of tobacco, vape, and other "next generation products," Arthur provides practical advice with respect to the rapidly-evolving issues in this dynamic and highly regulated product category.  As part of his practice, Arthur works with experts around the world in a wide range of research and clinical disciplines.

In addition to his product liability experience, Arthur has handled a variety of commercial litigation in both federal and New York State trial and appellate courts. He has also represented defendants in multidistrict litigations in the United States arising out of overseas terrorist attacks on civil aviation and has conducted investigations and discovery in countries in Europe and on the Indian subcontinent.

Bar admissionsNew York
CourtsUnited States Court of Appeals for the Second CircuitUnited States District Court for the Southern District of New YorkUnited States District Court for the Eastern District of New York

EXPERIENCE

Partner in DLA Piper’s Product Liability practice group within the Consumer Goods, Food and Retail Sector.
Education
  • J.D., Boston University School of Law 1983
    Edward F. Hennessey Distinguished Scholar
    Probate Law Journal, Note & Case Editor
    cum laude
  • Stony Brook University
    B.A., Political Science, 1980
    Pi Sigma Alpha

Awards

  • The Legal 500 United States
    2021 - Recommended, Product Liability, Mass Tort and Class Action: Consumer Products (including Tobacco)
    2021 - Recommended, Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices - Defense

Pro Bono

Arthur’s pro bono work focuses on access to justice.  He supports the work of the California Innocence Project and regularly assesses post-conviction claims of innocence.  Arthur has also worked with the immigration and refugee advocacy organization HIAS to assist in preparing U nonimmigrant visa applications for foreign nationals who were victims of crime in the U.S. and are willing to assist law enforcement in investigating and prosecuting the crime.

Publications

  • Scharf, S. A., Sax, G. D., & Marmor, S. R. (Eds.). (2021). Product Liability Litigation: Current Law, Strategies and Best Practices (Second Edition ed. Vol. 1). Scharf, S. A., Sax, G. D., & Marmor, S. R. (Eds.). (2021). Product Liability Litigation: Current Law, Strategies and Best Practices (Second Edition ed. Vol. 1); Hoffmann, A., Contributor; § 8.9: Traditional Tobacco Litigation: United States: PLI Press.
  • Hoffmann, A., & Gismondi, C. (2020). Is synthetic CBD a controlled substance under the Controlled Substances Act? Cannabis Bus. Exec. Retrieved from https://www.cannabisbusinessexecutive.com/2020/04/is-synthetic-cbd-a-controlled-substance-under-the-controlled-substances-act# 

Connect